Published in Medical Letter on the CDC and FDA, August 4th, 1997
Increasing drug resistance has complicated the control of Plasmodium vivax, the most common cause of human malaria, noted Claudia F. Golenda, Walter Reed Army Institute of Research, Washington, D.C., and colleagues ("Continuous in vitro Propagation of the Malaria Parasite Plasmodium vivax," Proceedings of the National Academy of Sciences USA, 1997;94:6786-6791).
"The ability to culture P. vivax opens new opportunities to develop vaccines, test drugs, and clone parasites for genome sequencing," wrote Golenda et...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.